Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical Investigation

  • Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
    You have access
    Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
    Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 794-800; DOI: https://doi.org/10.2967/jnumed.121.262506
  • 
    Initial Clinical Experience with <sup>90</sup>Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
    You have access
    Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
    Justin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, Manuel Weber, Nader Hirmas, Karina Kostbade, Sebastian Bauer, Martin Schuler, Marit Ahrens, Hans-Ulrich Schildhaus, Christoph Rischpler, Hong Grafe, Jens T. Siveke, Ken Herrmann, Wolfgang P. Fendler and Rainer Hamacher
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 727-734; DOI: https://doi.org/10.2967/jnumed.121.262468
  • Biodistribution of <sup>18</sup>F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader
    You have access
    Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader
    Ramsha Iqbal, Maqsood Yaqub, Daniela E. Oprea-Lager, Yeukman Liu, Anne Marije Luik, Andy P. Beelen, Robert C. Schuit, Albert D. Windhorst, Ronald Boellaard and Catharina W. Menke-van der Houven van Oordt
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 694-699; DOI: https://doi.org/10.2967/jnumed.121.262500
  • 
    <sup>18</sup>F-4FMFES and <sup>18</sup>F-FDG PET/CT in Estrogen Receptor–Positive Endometrial Carcinomas: Preliminary Report
    You have access
    18F-4FMFES and 18F-FDG PET/CT in Estrogen Receptor–Positive Endometrial Carcinomas: Preliminary Report
    Michel Paquette, Esteban Espinosa-Bentancourt, Éric Lavallée, Serge Phoenix, Korine Lapointe-Milot, Paul Bessette, Brigitte Guérin and Éric E. Turcotte
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 702-707; DOI: https://doi.org/10.2967/jnumed.121.262617
  • 
    <sup>11</sup>C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
    You have access
    11C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
    Asim K. Bag, Melissa N. Wing, Noah D. Sabin, Scott N. Hwang, Gregory T. Armstrong, Yuanyuan Han, Yimei Li, Scott E. Snyder, Giles W. Robinson, Ibrahim Qaddoumi, Alberto Broniscer, John T. Lucas and Barry L. Shulkin
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 664-671; DOI: https://doi.org/10.2967/jnumed.120.261891
  • 
    <sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
    You have access
    18F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
    Joseph G. Crompton, Wesley R. Armstrong, Mark A. Eckardt, Ameen Seyedroudbari, William D. Tap, Sarah M. Dry, Evan R. Abt, Jeremie Calais, Ken Herrmann, Johannes Czernin, Fritz C. Eilber and Matthias R. Benz
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 708-712; DOI: https://doi.org/10.2967/jnumed.121.262502
  • 
    <sup>90</sup>Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
    You have access
    90Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study
    Benedikt M. Schaarschmidt, Moritz Wildgruber, Roman Kloeckner, James Nie, Verena Steinle, Arthur J.A.T. Braat, Fabian Lohoefer, Hyun S. Kim, Harald Lahner, Manuel Weber and Jens Theysohn
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 679-685; DOI: https://doi.org/10.2967/jnumed.121.262561
  • Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
    Open Access
    Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
    Jasper Vonk, Jaron G. de Wit, Floris J. Voskuil, Yang Hang Tang, Wouter T.R. Hooghiemstra, Matthijs D. Linssen, Evert van den Broek, Jan J. Doff, Sebastiaan A.H.J. de Visscher, Kees-Pieter Schepman, Bert van der Vegt, Gooitzen M. van Dam and Max J.H. Witjes
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 672-678; DOI: https://doi.org/10.2967/jnumed.121.262530
  • PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer
    You have access
    PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer
    Jasper Smit, Frank J. Borm, Anna-Larissa N. Niemeijer, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Daniela E. Oprea-Lager, Danielle J. Vugts, Guus A.M.S. van Dongen, Berlinda J. de Wit-van der Veen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 686-693; DOI: https://doi.org/10.2967/jnumed.121.262473
  • Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
    You have access
    Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
    Erwin Woff, Lisa Salvatore, Federica Marmorino, Dario Genovesi, Gabriela Critchi, Thomas Guiot, Lieveke Ameye, Francesco Sclafani, Alain Hendlisz and Patrick Flamen
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 549-555; DOI: https://doi.org/10.2967/jnumed.120.245357

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 49
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire